The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: A clustered systematic review and meta-analysis

医学 恶性胸腔积液 胸膜成形术 内科学 荟萃分析 胸腔积液 中医药 随机对照试验 肿瘤科 病理 替代医学
作者
Cheng-Qiong Wang,Jiao Xu,Hong Jiang,Xiao-Tian Zheng,Yan Zhang,Xiao-Rong Huang,Fei She,Teng-Yang Fan,Lin Zhan,Jihong Feng,Qihai Gong,Xue Xiao,Xiaofan Chen,Zheng Xiao
出处
期刊:Phytomedicine [Elsevier BV]
卷期号:115: 154847-154847 被引量:6
标识
DOI:10.1016/j.phymed.2023.154847
摘要

Aidi injection (Aidi), a traditional Chinese medicine injection, is often practiced to control malignant pleural effusion (MPE). We performed a registered systematic review and meta-analysis (PROSPERO: CRD42022337611) to clarify the clinical role of Aidi in MPE, reveal optimal combinations of Aidi and chemical agents, their indications, therapeutic route and usage, and demonstrate their clinical effectiveness and safety. All randomized controlled trials (RCTs) about Aidi in controlling MPE were collected from Chinese and English databases (up to October 2022). We clustered them into multiple homogenous regimens, evaluated the risk-of-bias at outcome level using a RoB 2, extracted and pooled the data using meta-analysis or descriptive analysis, and finally summarized their evidence quality. All 56 studies were clustered into intrapleural administration with Aidi alone or plus chemical agents, and intravenous administration with Aidi for MPE. Intrapleural administration with Aidi alone displayed similar clinical responses on Cisplatin (DDP) alone. Only administration with Aidi plus DDP significantly improved complete response and quality of life, and displayed a low pleurodesis failure, disease progression, hematotoxicity, gastrointestinal and hepatorenal toxicity. For patients with moderate to massive effusion, Karnofsky Performance Status score ≥ 50 or anticipated survival time ≥3 months, Aidi (50 ml to 80 ml each time, one time each week and three to eight times) plus DDP (20 to 30 mg, 40 to 50 mg, or 60 to 80 mg each time) significantly improved clinical responses. Most results had moderate to low quality. Current evidences indicate that Aidi, a pleurodesis agent, plays an interesting clinical role in controlling MPE. Aidi plus DDP perfusion is a most commonly used regimen, which shows a significant improvement in clinical responses. These findings also provide an indication and possible optimal usage for rational drug use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
彭于晏应助清风采纳,获得10
刚刚
刚刚
刚刚
1秒前
东方元语应助好好学习采纳,获得10
1秒前
Micale完成签到,获得积分10
1秒前
ygrz发布了新的文献求助10
1秒前
1秒前
1秒前
1秒前
1秒前
2秒前
three发布了新的文献求助20
2秒前
Orange应助我是蝈蝈采纳,获得10
2秒前
领导范儿应助我是蝈蝈采纳,获得10
2秒前
Orange应助我是蝈蝈采纳,获得10
2秒前
JamesPei应助我是蝈蝈采纳,获得10
2秒前
卧镁铀钳发布了新的文献求助20
2秒前
汉堡包应助我是蝈蝈采纳,获得10
2秒前
研友_VZG7GZ应助我是蝈蝈采纳,获得10
2秒前
科研通AI6.4应助cheche采纳,获得10
2秒前
小马甲应助我是蝈蝈采纳,获得10
2秒前
Sea_U应助我是蝈蝈采纳,获得10
2秒前
隐形曼青应助我是蝈蝈采纳,获得30
3秒前
科研通AI6.1应助我是蝈蝈采纳,获得10
3秒前
3秒前
QWE发布了新的文献求助10
3秒前
liaolu完成签到 ,获得积分10
3秒前
小米粥发布了新的文献求助10
3秒前
好运常在完成签到,获得积分10
3秒前
tougerr发布了新的文献求助30
3秒前
3秒前
乐乐应助haha采纳,获得20
4秒前
4秒前
科大第一深情完成签到,获得积分10
4秒前
科目三应助锦鲤采纳,获得10
4秒前
咸芋咸鱼发布了新的文献求助10
4秒前
4秒前
lemon完成签到,获得积分10
4秒前
4秒前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
久松真一著作集〈第5巻〉禅と芸術 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6557033
求助须知:如何正确求助?哪些是违规求助? 8340917
关于积分的说明 17870596
捐赠科研通 5675971
什么是DOI,文献DOI怎么找? 2940837
邀请新用户注册赠送积分活动 1916679
关于科研通互助平台的介绍 1787511